Fundraising Fox
Corey Goodman
InvestorUnicorn founderChairman at Alx Oncology · General Partner at venBio Global Strategic · Managing Partner at venBio Partners · Managing Partner – Venbio Partners, Adj. Professor of Neuroscience, UC Berkeley at Berkeley Frontier
San Francisco, California
Writes $20M – $30M checks · typically $25M
FoundedAlx Oncology$3B
Find your path to Corey
Sign up to see every warm intro you have to Corey
- Paths you didn't know you had: your email and LinkedIn already hold routes to Corey. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Corey Goodman pairs deep neuroscience expertise in neural wiring and axon guidance molecules with hands-on company building—founding eight biotechs including Exelixis and leading Pfizer's Biotherapeutics to align science with pharma acquisition needs.
Invests in
BiotechHealthtech
Chairman at Alx Oncology
Intro paths
In turn, Corey can intro founders to Alx Oncology's investors below.
Alx Oncology's investors · 8
Deals · 2
AttralusBoard seat
via venBio Partners · filed Sep 2021 · $116.6M raise
Alexo TherapeuticsBoard seat
via venBio Partners · filed May 2015 · $36M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Investor
Alx OncologyCheckmate PharmaceuticalsGood2Go, IncHeart MetabolicsInsamoMindRhythmParabilis MedicinesQueenlyTallac Therapeutics
Sources: SEC Form D filings · curated public sources.
Colleagues at venBio Global Strategic
Network5
Investors connected to Corey in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Corey Goodman?
- Corey Goodman pairs deep neuroscience expertise in neural wiring and axon guidance molecules with hands-on company building—founding eight biotechs including Exelixis and leading Pfizer's Biotherapeutics to align science with pharma acquisition needs.
- Where does Corey Goodman work?
- Corey Goodman is Chairman of Alx Oncology and General Partner at venBio Global Strategic and Managing Partner at venBio Partners and Managing Partner – Venbio Partners, Adj. Professor of Neuroscience, UC Berkeley at Berkeley Frontier.
- What does Corey Goodman invest in?
- Corey Goodman invests in Biotech, Healthtech.
- What check size does Corey Goodman write?
- Corey Goodman typically writes checks of $20M – $30M.
- What companies did Corey Goodman found?
- Corey Goodman founded Alx Oncology.
- What boards does Corey Goodman sit on?
- Corey Goodman holds tracked board seats at Alexo Therapeutics, Attralus, Tallac Therapeutics.
- What companies has Corey Goodman invested in?
- Investments tracked here include Alx Oncology, Checkmate Pharmaceuticals, Good2Go, Inc, Heart Metabolics, Insamo, MindRhythm, Parabilis Medicines, Queenly, Tallac Therapeutics.
Founder mafias
Berkeley Frontier mafia5
Also came through, then founded or led a company.
Axonis Therapeutics mafia2
Also came through, then founded or led a company.
Solstice Biologics mafia2
Also came through, then founded or led a company.
Tallac Therapeutics mafia2
Also came through, then founded or led a company.
venBio Partners mafia2
Also came through, then founded or led a company.
About this profile. Compiled from public sources — venBio Global Strategic's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights